Species: Aggregatibacter segnis (HMT-0762) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0762: [Body Sites Data]
[Taxon Description]
| Life Page: Aggregatibacter segnis
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.15 | 0.28 | 0.13 | 0.26 | 0.14 | 0.04 | 0.16 | 0.02 | 0.05 | 0.05 | 0.01 | 0 | 0 | 0.03 | 0 | 0.02 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.02 | 0.02 | 0 | 0.04 | 0.04 | 0.04 | 0.03 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| 90thp | 0.30 | 0.69 | 0.39 | 0.82 | 0.29 | 0.04 | 0.35 | 0.04 | 0.11 | 0.10 | 0.01 | 0.01 | 0 | 0.03 | 0 | 0.06 | 0 | 0 |
| Stdev | 0.17 | 0.37 | 0.36 | 0.39 | 0.11 | 0 | 0.15 | 0.02 | 0.05 | 0.05 | 0.01 | 0.01 | 0 | 0 | 0 | 0.06 | 0.01 | 0 |
| Prev(%) | 45.83 | 64.56 | 16.67 | 20.00 | 11.15 | 0 | 0 | 0 | 4.55 | 11.11 | 1.54 | 0 | 0 | 0 | 0 | 12.50 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to A. segnis, A. sp. HMT 512, and A. sp. HMT 513 were assigned one-third to each taxon.
Reads equally close to A. segnis, A. sp. HMT 512, and A. sp. HMT 513 were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.13 | 0.15 | 0 | 0.02 | 0.01 | 0.06 | 0.01 | 0.04 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.34 | 0.33 | 0.01 | 0.04 | 0.03 | 0.20 | 0.03 | 0.04 | 0.01 | 0 |
| Stdev | 0.37 | 0.41 | 0.02 | 0.08 | 0.05 | 0.12 | 0.05 | 0.27 | 0.05 | 0 |
| Prev(%) | 42.57 | 50.00 | 10.81 | 31.08 | 31.08 | 49.32 | 29.05 | 30.41 | 20.95 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.05 | 0.04 | 0.02 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.15 | 0.11 | 0.02 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.12 | 0.11 | 0.12 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 45.70 | 31.13 | 20.28 | 0 | 0 | 29.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-512 nor HMT-762 were present singularly so these reads were split evenly at these sites (AKE,HPA,LRC,PTO,TDO).Because HMT-512 is not present individually, all equidistant reads were assigned to HMT-762 at these sites (BMU,SAL,SUBP,SUPP,THR).
Neither HMT-512 nor HMT-762 were present singularly so these reads were split evenly at these sites (AKE,HPA,LRC,PTO,TDO).Because HMT-512 is not present individually, all equidistant reads were assigned to HMT-762 at these sites (BMU,SAL,SUBP,SUPP,THR).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.49 | 0.41 | 0.05 | 0.24 | 0.04 | 0.32 | 0.29 | 0.09 | 0.01 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.25 | 1.20 | 0.08 | 0.59 | 0.10 | 0.92 | 0.25 | 0.12 | 0.04 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.08 | 0.88 | 0.19 | 0.85 | 0.10 | 0.57 | 2.67 | 0.42 | 0.04 | 0 | 0.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 75.31 | 69.02 | 30.62 | 54.09 | 41.43 | 68.16 | 42.99 | 51.09 | 33.09 | 0 | 15.92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.02 | 0.06 | 0.01 | 0.02 | 0.02 | 0.01 | 0 | 0.01 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.02 | 0.04 | 0.01 | 0.03 | 0.01 | 0.04 | 0 | 0.01 | 0 | 0 |
| Stdev | 0.08 | 0.32 | 0.07 | 0.06 | 0.11 | 0.03 | 0.02 | 0.01 | 0.01 | 0 |
| Prev(%) | 25.68 | 47.06 | 37.21 | 48.57 | 28.57 | 36.00 | 15.15 | 22.58 | 5.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.15 | 0.34 | 0.27 | 0.50 | 0.03 | 0 | 0.07 | 0.04 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.42 | 1.00 | 0.86 | 1.83 | 0.09 | 0 | 0.23 | 0.14 | 0.04 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.32 | 0.73 | 0.74 | 1.22 | 0.10 | 0 | 0.12 | 0.10 | 0.06 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 50.00 | 54.55 | 20.83 | 35.29 | 23.40 | 0 | 37.50 | 18.75 | 16.00 | 22.54 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

